Mirae Asset Global Investments Co., Ltd. Biomarin Pharmaceutical Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,795 shares of BMRN stock, worth $473,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,795
Previous 7,668
14.7%
Holding current value
$473,258
Previous $542,000
10.89%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding BMRN
# of Institutions
686Shares Held
186MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$849 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$813 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$661 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...